Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-03

Clinical Trial Update: Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing androgen ablation therapy with versus without chemotherapy in patients with metastatic hormone-sensitive prostate cancer; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androgen Ablation Therapy
  • Chemotherapy (chemotherapy)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Metastatic Hormone-sensitive Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-03-03